18.10.2013 • News

Toray Acquires U.S. Rival Zoltek

Leading Japanese carbon fibers manufacturer Toray is buying out its U.S. rival, family-owned Zoltek, for $584 million in cash, effective from the beginning of 2014, of earlier. The U.S. company, which had been grappling with mounting losses in the recent past, will become a wholly owned Toray subsidiary, but will continue to operate independently.

Principal shareholder Zsoltan Rumy, who tendered his own 18% stake in Zoltek to the Japanese group, said the handover to Toray "provides unique opportunities to drive the continued growth of our commercial carbon fibers business well into the future."  

 

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read